A randomised controlled trial of 3 strategies for the treatment of ARV-naive HIV-infected patients with tuberculosis

  • de Jong, Bouke (Copromotor)
  • Merle, Corinne (Partner)
  • Gninafon, Martin (Partner)
  • Sow, Oumou Bah (Partner)
  • Lo, Dr (Partner)
  • McIlleron, Helen (Partner)
  • Furco, Andre (Partner)
  • Galperine, Tatiana (Partner)

Project Details


The grant assessed, using a three-arm approach, whether aggressive
management of TB in HIV-infected patients during the 2 first months of
TB treatment with a high dose of rifampicin would result in a decrease in
the early HIV/TB mortality, without the negative effects of the early severe
complications that can arise from the use of early ARV treatment.
Effective start/end date20/01/1120/01/14